warnings
WARNINGS: Stop use and ask a physician if symptoms persist for more than 3 days or worsen.
Gelsemium Sempervirens 200ck
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Gelsemium Sempervirens 200ck
- Generic name
- GELSEMIUM SEMPERVIRENS ROOT
- Manufacturer
- SEVENE USA
- Product type
- HUMAN OTC DRUG
- SPL set ID
- c8d62cad-5581-86ae-e053-2995a90a8987
- SPL ID
- 2ddc4469-c277-f71e-e063-6394a90a7619
- Version
- 4
- Effective date
- 2025-02-11
- Source export date
- 2026-09-28
- Source partition
- 8
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:53:57
| Harmonized routes |
|---|
| SUBLINGUAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Gelsemium Sempervirens 200ck | openfda.brand_name | |
| generic name | GELSEMIUM SEMPERVIRENS ROOT | openfda.generic_name | |
| manufacturer name | SEVENE USA | openfda.manufacturer_name | |
| ndc | package | 76472-3014-1 | openfda.package_ndc |
| ndc | product | 76472-3014 | openfda.product_ndc |
| ndc11 | package | 76472301401 | derived:openfda.package_ndc |
| spl id | 2ddc4469-c277-f71e-e063-6394a90a7619 | id | |
| spl set id | c8d62cad-5581-86ae-e053-2995a90a8987 | set_id | |
| unii | 639KR60Q1Q | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.